Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey released on Tuesday. “The biggest risk to the AI-powered drug discovery thesis is not that AI fails ...
Source: [SCMP](https://www.scmp.com/business/china-business/article/3366863/china-embraces-ai-only-24-us-pharma-execs-bet-it-drug-making?utm_source=rss_feed)